Clinical trial
Investigation of Genetic Variations on Patients With Adverse Drug Events While on Direct Oral Anticoagulants (DOACs)
NCT04247919 is registered in ClinicalTrials.gov with Cipherome, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Investigation of Genetic Variations on Patients With Adverse Drug Events While on Direct Oral Anticoagulants (DOACs)
- Lead sponsor
- Cipherome, Inc.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- January 10, 2020
- Completion date
- July 24, 2020
- Enrollment
- 3 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.